StockData
BillionToOne, Inc. logo

BillionToOne, Inc. (BLLN) KPIs and segments

BLLNNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 11/30
$96.31−8.84 (-8.41%)

Close on Nov 16, 2026Market cap $4.54BP/E –Yield –

KPIs & segments

Operating metrics and segments that drive BillionToOne's business

BillionToOne's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.

The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.

Add to chartMetric
Q2 2026
Q1 2026
Q4 2025
Q3 2025
Q2 2025
Q1 2025
Q4 2024
Q3 2024
Prenatal($M)
94.296.586.174.160.956.143.236.6
Oncology($M)
13.710.79.148.694.952.181.091.14
Clinical trial support and other services($M)
1.541.140.810.760.770.710.760.68

Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).

Methodology and excluded metrics
  • Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).

Data updated 2026-08-05.

See a number that looks wrong?